Enact (ACT) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
ACT rises 1.0% to $45.67, 3 up days in a row. Closed at $45.67, +1.02% vs the prior close of $45.21. Day range $45.51–$46.37, opened at $45.92.
ACT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ACT rises 1.0% to $45.67, 3 up days in a row
- Closed at $45.67, +1.02% vs the prior close of $45.21. Day range $45.51–$46.37, opened at $45.92.
- Volume was 360.50K shares, 0.9x its 50-day average of 386.79K.
- Price is -4.9% vs its 50-day average ($48.02) and +4.0% vs its 200-day average ($43.92).
- 52-week range $34.64–$50.56; today's close sits at 69% of that range, 9.7% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — ACT rises 0.6% to $45.21
- Closed at $45.21, +0.62% vs the prior close of $44.93. Day range $44.06–$45.24, opened at $44.62.
- Volume was 459.40K shares, 1.2x its 50-day average of 387.22K.
- Price is -5.9% vs its 50-day average ($48.07) and +3.0% vs its 200-day average ($43.89).
- 52-week range $34.64–$50.56; today's close sits at 66% of that range, 10.6% below the 52-week high.
Oct 13, 2026 — ACT ends flat (+0.1%) to $44.93
- Closed at $44.93, +0.07% vs the prior close of $44.90. Day range $44.56–$45.39, opened at $45.33.
- Volume was 465.10K shares, 1.2x its 50-day average of 384.16K.
- Price is -6.6% vs its 50-day average ($48.12) and +2.4% vs its 200-day average ($43.87).
- 52-week range $34.64–$50.56; today's close sits at 65% of that range, 11.1% below the 52-week high.
Oct 12, 2026 — ACT dips 2.3% to $44.90
- Closed at $44.90, -2.33% vs the prior close of $45.97. Day range $44.87–$45.56, opened at $45.41.
- Volume was 310.30K shares, 0.8x its 50-day average of 386.14K.
- Price is -6.8% vs its 50-day average ($48.18) and +2.4% vs its 200-day average ($43.84).
- 52-week range $34.64–$50.56; today's close sits at 64% of that range, 11.2% below the 52-week high.
Oct 9, 2026 — ACT dips 1.4% to $45.97
- Closed at $45.97, -1.44% vs the prior close of $46.64. Day range $45.49–$46.69, opened at $46.58.
- Volume was 249.50K shares, 0.6x its 50-day average of 390.17K.
- Price is -4.7% vs its 50-day average ($48.23) and +4.9% vs its 200-day average ($43.82).
- 52-week range $34.64–$50.56; today's close sits at 71% of that range, 9.1% below the 52-week high.
Oct 8, 2026 — ACT rises 1.8% to $46.64
- Closed at $46.64, +1.79% vs the prior close of $45.82. Day range $45.61–$46.73, opened at $45.61.
- Volume was 261.20K shares, 0.7x its 50-day average of 393.68K.
- Price is -3.4% vs its 50-day average ($48.26) and +6.5% vs its 200-day average ($43.79).
- 52-week range $34.64–$50.56; today's close sits at 75% of that range, 7.8% below the 52-week high.
Oct 7, 2026 — ACT dips 1.1% to $45.82
- Closed at $45.82, -1.08% vs the prior close of $46.32. Day range $45.72–$46.31, opened at $46.05.
- Volume was 256.70K shares, 0.6x its 50-day average of 395.58K.
- Price is -5.1% vs its 50-day average ($48.29) and +4.7% vs its 200-day average ($43.76).
- 52-week range $34.64–$50.56; today's close sits at 70% of that range, 9.4% below the 52-week high.
Oct 6, 2026 — ACT rises 1.0% to $46.32, 4 up days in a row
- Closed at $46.32, +0.98% vs the prior close of $45.87. Day range $45.99–$46.45, opened at $45.99.
- Volume was 279.10K shares, 0.7x its 50-day average of 395.81K.
- Price is -4.2% vs its 50-day average ($48.33) and +5.9% vs its 200-day average ($43.73).
- 52-week range $34.64–$50.56; today's close sits at 73% of that range, 8.4% below the 52-week high.
- That makes 4 straight gains.
Oct 5, 2026 — ACT rises 1.3% to $45.87, 3 up days in a row
- Closed at $45.87, +1.35% vs the prior close of $45.26. Day range $45.23–$46.34, opened at $45.63.
- Volume was 454.20K shares, 1.1x its 50-day average of 395.85K.
- Price is -5.1% vs its 50-day average ($48.35) and +5.0% vs its 200-day average ($43.70).
- 52-week range $34.64–$50.56; today's close sits at 71% of that range, 9.3% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — ACT rises 2.5% to $45.26
- Closed at $45.26, +2.51% vs the prior close of $44.15. Day range $43.99–$45.61, opened at $44.23.
- Volume was 427.30K shares, 1.1x its 50-day average of 394.68K.
- Price is -6.4% vs its 50-day average ($48.37) and +3.6% vs its 200-day average ($43.67).
- 52-week range $34.64–$50.56; today's close sits at 67% of that range, 10.5% below the 52-week high.
Things to know before you trade ACT
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 3, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.35% (largest 6.8%).
- Liquidity: about 411.44K shares (≈$18.79M) trade per day on average.
- 52-week position: $45.67 vs a range of $34.64–$50.56 (69% of the range).
- Dividends: last ex-dividend date Aug 20, 2026 ($0.24/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 19 sales; latest: Holdings, Inc. Genworth sold 687,379 shares on Aug 31, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 5, 2026; 8-K May 15, 2026.
- Share count: 137.48M shares outstanding (Aug 3, 2026), -6.8% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Insurance Agents, Brokers & Service.
ACT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 45.92 | 46.37 | 45.51 | 45.67 | 360.50K |
| Oct 14, 2026 | 44.62 | 45.24 | 44.06 | 45.21 | 459.40K |
| Oct 13, 2026 | 45.33 | 45.39 | 44.56 | 44.93 | 465.10K |
| Oct 12, 2026 | 45.41 | 45.56 | 44.87 | 44.90 | 310.30K |
| Oct 9, 2026 | 46.58 | 46.69 | 45.49 | 45.97 | 249.50K |
| Oct 8, 2026 | 45.61 | 46.73 | 45.61 | 46.64 | 261.20K |
| Oct 7, 2026 | 46.05 | 46.31 | 45.72 | 45.82 | 256.70K |
| Oct 6, 2026 | 45.99 | 46.45 | 45.99 | 46.32 | 279.10K |
| Oct 5, 2026 | 45.63 | 46.34 | 45.23 | 45.87 | 454.20K |
| Oct 2, 2026 | 44.23 | 45.61 | 43.99 | 45.26 | 427.30K |
| Oct 1, 2026 | 43.13 | 44.37 | 43.13 | 44.15 | 604.90K |
| Sep 30, 2026 | 46.46 | 46.59 | 42.83 | 43.26 | 886.80K |
| Sep 29, 2026 | 46.87 | 46.87 | 46.08 | 46.44 | 324.80K |
| Sep 28, 2026 | 46.97 | 47.06 | 46.33 | 46.94 | 286.20K |
| Sep 25, 2026 | 47.31 | 47.50 | 46.51 | 46.97 | 258.10K |
| Sep 24, 2026 | 48.00 | 48.41 | 47.17 | 47.25 | 378.10K |
| Sep 23, 2026 | 47.46 | 47.86 | 46.97 | 47.75 | 313.80K |
| Sep 22, 2026 | 48.05 | 48.43 | 47.56 | 47.61 | 307.70K |
| Sep 21, 2026 | 48.71 | 49.03 | 48.01 | 48.05 | 246.40K |
| Sep 18, 2026 | 48.16 | 48.64 | 47.89 | 48.45 | 1.10M |
About Enact
Enact (ACT) is listed on the Nasdaq and classified by the SEC under “Insurance Agents, Brokers & Service”. Its business address is in RALEIGH, NC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1823529.
ACT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Dominic James Addesso | Chairperson of the Board | Sep 21, 2026 |
| Michael A Bless | Director | Sep 21, 2026 |
| John D Fisk | Director | Sep 21, 2026 |
| Rohit Gupta | President and CEO | Sep 21, 2026 |
| Sheila Hooda | Director | Sep 21, 2026 |
| H Elizabeth Mitchell | Director | Sep 21, 2026 |
| Robert P Jr Restrepo | Director | Sep 21, 2026 |
| Debra Still | Director | Sep 21, 2026 |
| Westley V Thompson | Director | Sep 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Derstine | EVP and Chief Risk Officer | Sep 21, 2026 |
| Brian Gould | EVP & Chief Operations Officer | Sep 21, 2026 |
| Rohit Gupta | President and CEO | Sep 21, 2026 |
| James Mcmullen | Controller | Sep 21, 2026 |
| Hardin Dean Mitchell | EVP, CFO and Treasurer | Sep 21, 2026 |
| Evan Stolove | EVP, Gen. Counsel & Secretary | Sep 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 31, 2026 | Holdings, Inc. Genworth | Sale | 687,379 | $49.40 |
| Aug 17, 2026 | Evan Stolove | Sale | 20,024 | $49.52 |
| Jul 31, 2026 | Holdings, Inc. Genworth | Sale | 523,226 | $45.92 |
| Jun 30, 2026 | Holdings, Inc. Genworth | Sale | 605,067 | $42.28 |
| Jun 1, 2026 | Brian Gould | Sale | 23,000 | $41.18 |
| May 29, 2026 | Holdings, Inc. Genworth | Sale | 602,440 | $42.91 |
| Apr 30, 2026 | Holdings, Inc. Genworth | Sale | 560,453 | $42.55 |
| Mar 31, 2026 | Holdings, Inc. Genworth | Sale | 820,567 | $40.92 |
| Mar 6, 2026 | James Mcmullen | Sale | 2,500 | $41.64 |
| Mar 2, 2026 | Michael Derstine | Sale | 9,000 | $42.21 |
| Feb 27, 2026 | Holdings, Inc. Genworth | Sale | 398,731 | $42.19 |
| Feb 11, 2026 | Robert P Jr Restrepo | Sale | 5,000 | $42.95 |
| Jan 30, 2026 | Holdings, Inc. Genworth | Sale | 634,953 | $39.37 |
| Dec 31, 2025 | Holdings, Inc. Genworth | Sale | 908,673 | $39.47 |
| Nov 28, 2025 | Holdings, Inc. Genworth | Sale | 878,006 | $37.36 |
ACT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.24B | $674.24M | 4.52 | $724.52M |
| Dec 31, 2024 | $1.20B | $688.07M | 4.37 | $686.26M |
| Dec 31, 2023 | $1.15B | $665.51M | 4.11 | $632.04M |
| Dec 31, 2022 | $1.10B | — | 4.31 | $560.51M |
| Dec 31, 2021 | $1.12B | $546.68M | 3.36 | $572.11M |
Latest balance sheet: total assets $6.96B, total liabilities $1.56B, cash $448.45M (as of Jun 30, 2026).
ACT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $47.83 |
| May 5, 2026 | 8-K Item 2.02 (results) | $42.31 |
| Feb 3, 2026 | 8-K Item 2.02 (results) | $40.33 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $35.93 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $34.42 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $35.79 |
| Feb 4, 2025 | 8-K Item 2.02 (results) | $33.61 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $34.03 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 6, 2024 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
More on ACT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.